Search results
Microsoft, OpenAI Chase Google in AI Search as Senate Passes AI Deepfakes Bill
CNET· 1 day agoAsk anyone who has more than passing knowledge of how generative AI chatbots, like ChatGPT, work and...
US spot ether ETFs make market debut in another win for crypto industry
Reuters· 3 days agoU.S. exchange-traded funds (ETFs) tied to the price of ether enjoyed a strong debut on Tuesday, with...
IRS Reveals What It Looks For In Stock Option Audits
Forbes· 3 days agoDepending on what IRS examiners find, an audit of a company can lead to individual audits, and maybe even amended personal tax returns, for its ...
Opinion | How Long Will A.I.’s ‘Slop’ Era Last?
New York Times· 3 days agoIn a note from Barclays, one analyst warned that today’s A.I. investments might be three times as large as expected returns, while another analyst, in...
Council Post: Logistics Management: Outsourcing Vs. In-House
Forbes· 5 days agoHere are some considerations, advantages and challenges for each option.
DEFENCE THERAPEUTICS GRANTED CNRI-H FROM THE CANADIAN NUCLEAR LABORATORIES TO ACCELERATE THE DEVELOP
PharmiWeb· 4 days agoDefence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies ...
ViiV Healthcare announces positive data demonstrating 2-drug regimen Dovato is as effective as...
PharmiWeb· 5 days agoLondon, [23 JULY 2024] – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announces 48-week findings from PASO DOBLE (GeSIDA ...